Skip to main content
. Author manuscript; available in PMC: 2018 Apr 4.
Published in final edited form as: Mol Immunol. 2017 Sep 5;93:246–252. doi: 10.1016/j.molimm.2017.06.036

Fig. 2.

Fig. 2

Inactivation of DAF’s function by nonenzymatic glycation. Purified Ehu DAF (20 g/ml) was incubated with either 0.5 M ribose (open circle) or buffer (control; closed circle) as described in Methods. Following incubation of this modified DAF protein with antibody-sensitized guinea pig erythrocytes (EgpA), the erythrocytes were incubated with increasing percentages of human serum (containing complement), and lysis quantitated. Whereas hemolysis of EgpA, was reduced by native non-glycated DAF, hemolysis of EgpA treated with glycated DAF was nearly identical to that of untreated EgpA control not exposed to DAF (closed triangles).